[1] |
Rothemund PW.Folding DNA to create nanoscale shapes and patterns[J].Nature,2006, 440: 297-302.
|
[2] |
Jiang Q, Liu S, Liu J, et al.Rationally designed DNA-origami nanomaterials for drug delivery in vivo[J].Adv Mater,2019, 31: e1804785. doi: 10.1002/adma.201804785.
|
[3] |
Zhou T, Yuan Z, Weng J, et al.Challenges and advances in clinical applications of mesenchymal stromal cells[J].J Hematol Oncol,2021, 14: 24. doi: 10.1186/s13045-021-01037-x.
|
[4] |
Qin H, Zhao A.Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics[J].Protein Cell,2020, 11: 707-722.
|
[5] |
Fischer UM, Harting MT, Jimenez F, et al.Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect[J].Stem Cells Dev,2009, 18: 683-692.
|
[6] |
Lee RH, Pulin AA, Seo MJ, et al.Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6[J].Cell Stem Cell,2009, 5: 54-63.
|
[7] |
Schoenit A, Cavalcanti-Adam EA, Gopfrich K.Functionalization of cellular membranes with DNA nanotechnology[J].Trends Biotechnol,2021, 39: 1208-1220.
|
[8] |
Kick B, Praetorius F, Dietz H, et al.Efficient production of single-stranded phage DNA as scaffolds for DNA origami[J].Nano Lett,2015, 15: 4672-4676.
|
[9] |
Wang Z, Song L, Liu Q, et al.A Tubular DNA nanodevice as a siRNA/chemo-drug co-delivery vehicle for combined cancer therapy[J].Angew Chem Int Ed Engl,2021, 60: 2594-2598.
|
[10] |
Wang H, Wang R, Cai K, et al.Selective in vivo metabolic cell-labeling-mediated cancer targeting[J].Nat Chem Biol,2017, 13: 415-424.
|
[11] |
Jiang D, Ge Z, Im HJ, et al.DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury[J].Nat Biomed Eng,2018, 2: 865-877.
|